Search Results
Search for other papers by Mabel E Bohórquez in
Google Scholar
PubMed
Search for other papers by Ana P Estrada in
Google Scholar
PubMed
Search for other papers by Jacob Stultz in
Google Scholar
PubMed
Search for other papers by Ruta Sahasrabudhe in
Google Scholar
PubMed
Search for other papers by John Williamson in
Google Scholar
PubMed
Search for other papers by Paul Lott in
Google Scholar
PubMed
Search for other papers by Carlos S Duque in
Google Scholar
PubMed
Search for other papers by Jorge Donado in
Google Scholar
PubMed
Search for other papers by Gilbert Mateus in
Google Scholar
PubMed
Search for other papers by Fernando Bolaños in
Google Scholar
PubMed
Search for other papers by Alejandro Vélez in
Google Scholar
PubMed
Search for other papers by Magdalena Echeverry in
Google Scholar
PubMed
Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California, USA
Fundación de Genética y Genómica, Medellín, Colombia
Search for other papers by Luis G Carvajal-Carmona in
Google Scholar
PubMed
Familial nonmedullary thyroid cancer (NMTC) has not been clearly linked to causal germline variants, despite the large role that genetic factors play in risk. Recently, HABP2 G534E (rs7080536A) has been implicated as a causal variant in NMTC. We have previously shown that the HABP2 G534E variant is not associated with TC risk in patients from the British Isles. Hispanics are the largest and the youngest minority in the United States and NMTC is now the second most common malignancy in women from this population. In order to determine if the HABP2 G534E variant played a role in NMTC risk among Hispanic populations, we analyzed 281 cases and 1105 population-matched controls from a multicenter study in Colombia, evaluating the association through logistic regression. We found that the HABP2 G534E variant was not significantly associated with NMTC risk (P=0.843) in this Hispanic group. We also stratified available clinical data by multiple available clinicopathological variables and further analyzed the effect of HABP2 on NMTC presentation. However, we failed to detect associations between HABP2 G534E and NMTC risk, regardless of disease presentation (P≥0.273 for all cases). Therefore, without any significant associations between the HABP2 G534E variant and NMTC risk, we conclude that the variant is not causal of NMTC in this Hispanic population.
